Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Julie Higgins is active.

Publication


Featured researches published by Julie Higgins.


Nature Genetics | 2005

A centrosomal mechanism involving CDK5RAP2 and CENPJ controls brain size

Jacquelyn Bond; Emma Roberts; Kelly Springell; Sophia Lizarraga; Sheila Scott; Julie Higgins; Daniel J. Hampshire; Ewan E. Morrison; Gabriella F Leal; Elias O Silva; Suzana Maria Ramos Costa; Diana Baralle; Michela Raponi; Gulshan Karbani; Yasmin Rashid; Hussain Jafri; Christopher Bennett; Peter Corry; Christopher A. Walsh; C. Geoffrey Woods

Autosomal recessive primary microcephaly is a potential model in which to research genes involved in human brain growth. We show that two forms of the disorder result from homozygous mutations in the genes CDK5RAP2 and CENPJ. We found neuroepithelial expression of the genes during prenatal neurogenesis and protein localization to the spindle poles of mitotic cells, suggesting that a centrosomal mechanism controls neuron number in the developing mammalian brain.


Nature Cell Biology | 2015

An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes

Gabrielle Wheway; Miriam Schmidts; Dorus A. Mans; Katarzyna Szymanska; Thanh Minh T Nguyen; Hilary Racher; Ian G. Phelps; Grischa Toedt; Julie Kennedy; Kirsten A. Wunderlich; Nasrin Sorusch; Zakia Abdelhamed; Subaashini Natarajan; Warren Herridge; Jeroen van Reeuwijk; Nicola Horn; Karsten Boldt; David A. Parry; Stef J.F. Letteboer; Susanne Roosing; Matthew Adams; Sandra M. Bell; Jacquelyn Bond; Julie Higgins; Ewan E. Morrison; Darren C. Tomlinson; Gisela G. Slaats; Teunis J. P. van Dam; Lijia Huang; Kristin Kessler

Defects in primary cilium biogenesis underlie the ciliopathies, a growing group of genetic disorders. We describe a whole-genome siRNA-based reverse genetics screen for defects in biogenesis and/or maintenance of the primary cilium, obtaining a global resource. We identify 112 candidate ciliogenesis and ciliopathy genes, including 44 components of the ubiquitin–proteasome system, 12 G-protein-coupled receptors, and 3 pre-mRNA processing factors (PRPF6, PRPF8 and PRPF31) mutated in autosomal dominant retinitis pigmentosa. The PRPFs localize to the connecting cilium, and PRPF8- and PRPF31-mutated cells have ciliary defects. Combining the screen with exome sequencing data identified recessive mutations in PIBF1, also known as CEP90, and C21orf2, also known as LRRC76, as causes of the ciliopathies Joubert and Jeune syndromes. Biochemical approaches place C21orf2 within key ciliopathy-associated protein modules, offering an explanation for the skeletal and retinal involvement observed in individuals with C21orf2 variants. Our global, unbiased approaches provide insights into ciliogenesis complexity and identify roles for unanticipated pathways in human genetic disease.


BMC Cell Biology | 2010

Human ASPM participates in spindle organisation, spindle orientation and cytokinesis

Julie Higgins; Carol Midgley; Anna-Maria Bergh; Sandra M. Bell; Jonathan M. Askham; Emma Roberts; Ruth K Binns; Saghira Malik Sharif; Christopher Bennett; David M. Glover; C. Geoffrey Woods; Ewan E. Morrison; Jacquelyn Bond

BackgroundMutations in the A bnormal Sp indle M icrocephaly related gene (ASPM) are the commonest cause of autosomal recessive primary microcephaly (MCPH) a disorder characterised by a small brain and associated mental retardation. ASPM encodes a mitotic spindle pole associated protein. It is suggested that the MCPH phenotype arises from proliferation defects in neural progenitor cells (NPC).ResultsWe show that ASPM is a microtubule minus end-associated protein that is recruited in a microtubule-dependent manner to the pericentriolar matrix (PCM) at the spindle poles during mitosis. ASPM siRNA reduces ASPM protein at the spindle poles in cultured U2OS cells and severely perturbs a number of aspects of mitosis, including the orientation of the mitotic spindle, the main determinant of developmental asymmetrical cell division. The majority of ASPM depleted mitotic cells fail to complete cytokinesis. In MCPH patient fibroblasts we show that a pathogenic ASPM splice site mutation results in the expression of a novel variant protein lacking a tripeptide motif, a minimal alteration that correlates with a dramatic decrease in ASPM spindle pole localisation. Moreover, expression of dominant-negative ASPM C-terminal fragments cause severe spindle assembly defects and cytokinesis failure in cultured cells.ConclusionsThese observations indicate that ASPM participates in spindle organisation, spindle positioning and cytokinesis in all dividing cells and that the extreme C-terminus of the protein is required for ASPM localisation and function. Our data supports the hypothesis that the MCPH phenotype caused by ASPM mutation is a consequence of mitotic aberrations during neurogenesis. We propose the effects of ASPM mutation are tolerated in somatic cells but have profound consequences for the symmetrical division of NPCs, due to the unusual morphology of these cells. This antagonises the early expansion of the progenitor pool that underpins cortical neurogenesis, causing the MCPH phenotype.


PLOS ONE | 2014

High-Content, High-Throughput Screening for the Identification of Cytotoxic Compounds Based on Cell Morphology and Cell Proliferation Markers

Heather L. Martin; Matthew Adams; Julie Higgins; Jacquelyn Bond; Ewan E. Morrison; Sandra M. Bell; Stuart L. Warriner; Adam Nelson; Darren C. Tomlinson

Toxicity is a major cause of failure in drug discovery and development, and whilst robust toxicological testing occurs, efficiency could be improved if compounds with cytotoxic characteristics were identified during primary compound screening. The use of high-content imaging in primary screening is becoming more widespread, and by utilising phenotypic approaches it should be possible to incorporate cytotoxicity counter-screens into primary screens. Here we present a novel phenotypic assay that can be used as a counter-screen to identify compounds with adverse cellular effects. This assay has been developed using U2OS cells, the PerkinElmer Operetta high-content/high-throughput imaging system and Columbus image analysis software. In Columbus, algorithms were devised to identify changes in nuclear morphology, cell shape and proliferation using DAPI, TOTO-3 and phosphohistone H3 staining, respectively. The algorithms were developed and tested on cells treated with doxorubicin, taxol and nocodazole. The assay was then used to screen a novel, chemical library, rich in natural product-like molecules of over 300 compounds, 13.6% of which were identified as having adverse cellular effects. This assay provides a relatively cheap and rapid approach for identifying compounds with adverse cellular effects during screening assays, potentially reducing compound rejection due to toxicity in subsequent in vitro and in vivo assays.


Journal of Biomolecular Screening | 2014

A high-throughput assay to identify modifiers of premature chromosome condensation.

Matthew Adams; Victoria J. Cookson; Julie Higgins; Heather L. Martin; Darren C. Tomlinson; Jacquelyn Bond; Ewan E. Morrison; Sandra M. Bell

Premature chromosome condensation (PCC) is a consequence of early mitotic entry, where mitosis begins before completion of DNA replication. Previously we have identified mutations in MCPH1, a DNA damage response and potential tumor suppressor gene, as a cause of primary microcephaly and PCC. Here we describe a high-throughput assay to identify modifiers of PCC. Reverse transfection of control siRNA followed by a forward transfection of MCPH1 small interfering RNA (siRNA) was performed to induce PCC. Condensin II subunits CAPG2 and CAPH2 were validated as PCC modifiers and therefore positive controls. Cell nuclei were detected by DAPI staining using an Operetta imaging system. PCC and nuclei number were determined using Columbus analysis software. Two batches of nine plates were used to determine assay efficacy. Each plate contained four negative (nontargeting) and eight positive control siRNAs. Mean % PCC was 12.35% (n = 72) for negative controls and 4.25% (n = 144) for positive controls. Overall false-positive and false-negative rates were 0% (n = 72) and 2.1% (n = 144), respectively. This assay is currently being used to screen a human druggable genome siRNA library to identify novel therapeutic targets for cancer treatment. The assay can also be used to identify novel compounds and genes that induce PCC.


Mechanisms of Development | 2009

08-P015 Human ASPM participates in cleavage furrow orientation and cytokinesis

Julie Higgins; Carol Midgley; Geoffrey Woods; Jacquelyn Bond

During development of the vertebrate CNS, a precise control of planar orientation of the mitotic spindle of dividing neuroepithelial progenitors regulates the equal partitioning of apical attachment sites. This is necessary to maintain sister cells within the neuroepithelial structure. We have previously demonstrated an essential role for the G-protein regulator LGN in this process. Here we use three-dimensional time lapse imaging of dividing cells in the chick neuroepithelium and describe that the mitotic spindle follows a stereotypical biphasic rotation movement, which first drives the spindle to align with the neuroepithelial surface, then maintains it in this plane while leaving it free to revolve around the apico-basal axis of the cell. We show that Gai subunits, LGN and the dynein/dynactin interactor NuMA localize as nesting ring-shaped cortical domains on the lateral membrane of dividing cells. Gai-GDP recruits LGN, which in turn recruits NuMA to the cell cortex. LGN functions as a Gai-GDP sensor that changes conformation and is able to recruit NuMA only above a certain threshold of cortical Gai-GDP concentration. In absence of these molecules, spindle rotation is lost or erratic and the plane of division is randomized. We propose that a gradient of Gai-GDP is formed within the overall homogeneous cortical Gai distribution. A peak of Gai-GDP on the lateral cell cortex is used as a cue to define the progressively narrower rings of Gai, Gai-GDP/LGN and Gai-GDP/LGN/NuMA complexes on the lateral cell cortex. The latter domain controls astral microtubule stabilization to orients the spindle.


Neuro-oncology | 2016

P01.01 Ectopic expression of microRNA-1300 in adult and paediatric glioma cells induces cytokinesis failure and apoptosis via ECT2

Marjorie Boissinot; Henry King; Matthew Adams; Julie Higgins; Lynette Steele; Heiko Wurdak; Jacqueline Bond; Darren C. Tomlinson; Sean E. Lawler; Susan Short


Neuro-oncology | 2015

ATPS-48A HIGH-THROUGHPUT SCREEN IDENTIFIES microRNA-1300 AS A POTENTIAL THERAPEUTIC microRNA CAUSING CYTOKINESIS FAILURE AND APOPTOSIS IN GLIOBLASTOMA CELLS

Marjorie Boissinot; Matthew Adams; Julie Higgins; Henry King; Lynette Steele; Ruth Morton; Josie Hayes; Alastair Droop; Jacqueline Bond; Darren C. Tomlinson; Susan Short; Sean E. Lawler


Neuro-oncology | 2014

OP18IDENTIFICATION AND CHARACTERISATION OF MICRORNAS INVOLVED IN GLIOBLASTOMA CELL PROLIFERATION AND SURVIVAL

Marjorie Boissinot; Josie Hayes; Matthew Adams; Julie Higgins; Darren C. Tomlinson; Sean E. Lawler; Susan Short


Neuro-oncology | 2014

CB-03IDENTIFICATION AND CHARACTERISATION OF MicroRNAs INVOLVED IN GLIOBLASTOMA CELL PROLIFERATION AND SURVIVAL USING HIGH-THROUGHPUT SCREENING

Marjorie Boissinot; Josie Hayes; Matthew Adams; Julie Higgins; Darren C. Tomlinson; Sean E. Lawler; Susan Short

Collaboration


Dive into the Julie Higgins's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ewan E. Morrison

St James's University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sean E. Lawler

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Christopher Bennett

St James's University Hospital

View shared research outputs
Top Co-Authors

Avatar

Emma Roberts

St James's University Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge